Prasugrel in children with sickle cell disease: pharmacokinetic and pharmacodynamic data from an open-label, adaptive-design, dose-ranging study.

Styles, Lori; Heiselman, Darell; Heath, Lori E; Moser, Brian A; Small, David S; Jakubowski, Joseph A; Zhou, Chunmei; Redding-Lallinger, Rupa; Heeney, Matthew M; Quinn, Charles T; Rana, Sohail R; Kanter, Julie; Winters, Kenneth J.
J Pediatr Hematol Oncol; 37(1): 1-9, 2015 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-25493452